1. Stocks
  2. Cytek BioSciences Inc
  3. Swot
swot-logo

Cytek BioSciences Inc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Cytek BioSciences Inc has 17 Strengths, 10 Weaknesses, 5 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Positive Breakout Third Resistance ( LTP > R3)

Relative Outperformance versus Industry over 1 Month

Rising Net Cash Flow and Cash from Operating activity

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Positive Breakout (LTP > R2)

Positive breakout third resistance ( LTP > R3)

Companies with Low Debt

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Positive Breakout (LTP > R1)

High Volume, High Gain

Top Gainers

Stock with Low PE (PE < = 10)

Volume Shockers

High Volume, High Gain

Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score

Low DVM Stocks - Stocks to Exercise Caution On

Lowest Momentum Scores (Technical Scores)

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Low durability companies

Highest fall from 52 Week High

Degrowth in Quarterly Revenue and Profit in Recent Results(YoY)

Recent Results: Declining Operating Profit Margin and Net Profits (YoY)

Profit to Loss Companies

Stocks Underperforming their Industry Price Change in the Quarter

Mutual Funds Increased Shareholding in Past Month

Institutions increasing their shareholding

Mutual Funds Increased Shareholding over the Past Two Months

MFs increased their shareholding last quarter

Mf buying for 2 months